GlassScriptPhysician profile
James W Hampton
NPI 1508845801
$618.79
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $110 · 2021: $182 · 2022: $110.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $138.43 | 2019-2022 | |
| Innovation Technologies INC | $85.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $77.07 | 2019-2022 | |
| Abbvie INC. | $64.35 | 2020-2021 | |
| Avion Pharmaceuticals | $53.37 | 2020-2021 | |
| Ethicon US, LLC | $50.12 | 2019-2021 | |
| Coopersurgical, INC. | $31.06 | 2022 | |
| Merck Sharp & Dohme LLC | $29.20 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $23.29 | 2022 | |
| Duchesnay USA Incorporated | $15.87 | 2019 | |
| Novo Nordisk INC | $14.08 | 2022 | |
| Therapeuticsmd, INC. | $13.56 | 2019 | |
| Minerva Surgical, INC | $12.11 | 2021 | |
| Lupin INC. | $11.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hampton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.